Cmed is a UK based full service, oncology focused contract research organisation with operations in Romania, France and the USA. It specialises in complex disease areas, particularly oncology, immuno-oncology, cell therapy and other specialty therapeutics areas where clinical trials are increasingly complex and demanding. Cmed provides expertise and a next generation clinical data platform to a blue chip client base and has an established a track record of delivering early phase clinical projects quickly and cost effectively. Cmed has also developed encapsia, a next generation software suite for the remote gathering and management of clinical trial data.

Enterprise software

Sign up to SEP news